'Mucormycosis': A Fungal Infection Threatening India During COVID-19' - A Review

During the second wave of Covid-19 in India, doctors recently reported a outbreak of cases involving a rare infection-called the “black fungus”-among recovering and recovered Covid-19 patients. The frequency of bacterial and fungal coinfections has been continuously rising. At the same time, invasive pulmonary aspergillosis is increasingly being recognized in association with nCOVID-19. Currently, India is suffering from a newly maiming disease associated with nCOVID-19 infected patients; at the time of the treatment, it can be developed into rhino-orbital mucormycosis. There are some approved antifungal therapies for treating this fungal infection. The background, risk factors, and associated reports about the infection are described in this review.